Broker Check
Contact Info:
701 Fifth Avenue
Suite 4200
Seattle, WA 98104
206.623.6722 (MPCA)
844.422.6722 (MPCA)

Election behind us, Vaccines ahead

| November 16, 2020

If I dare say, the elections are behind us and we appear to have a new president starting on January 20th.  The only thing left is to figure out control of the Senate, which appears to be leaning red at this time. As we said last week, we think the “market” likes a divided government and thus had a nice rally last week.

That rally, though, was not wholly attributable to politics. Perhaps more influential was the news from Pfizer/BioNTech showing their vaccine trials were preliminarily showing a 90% effectiveness against COVID-19. We will find out more details as the trial progresses, but they will likely get emergency approval soon and we could see doses shipped this year potentially. But wait, there’s more!

Moderna came out this morning to say that their vaccine was 94.5% effective in trials thus far, one-upping Pfizer’s news last week. Another bonus for the Moderna vaccine is that it can be stored at a much more reasonable temperature, making shipping and distribution easier. There are a couple more companies (see below from our good friends at ARK Invest) that have related mRNA technology (a previously unproven technology in vaccines), with one holding the potential for a one dose solution. Let’s keep our fingers crossed that these vaccines continue to show great efficacy.


Not that it means much, but the DOW industrials are flirting with 30,000. Keep in mind that the DOW is a price weighted index, meaning that the stock with the highest dollar price has the highest weighting. Apple held the most sway until their share split earlier this year. It now looks like United Health, Home Depot, and are the three largest weighting. Keep in mind the index is only 30 companies, so it’s certainly not a perfect representation of the markets or the economy – but it’s worth looking at, regardless, as part of the bigger picture.


We noted last week that many of the indexes broke out of their trading bases and were setting up for higher levels, and that’s exactly what we got last week, with a continuation today. So what do the tea leaves say now?

We can see from the chart below that on a short-term view the markets are due for a pause. Longer term you can see that they have broken out after a long COVID pullback and recovery. Typically, the breakout will lead to further movement in that direction (in this case it happens to be up). We would expect a rotation to areas that have underperformed over the last couple years and especially this year. Those would likely be energy, financials, and industrial companies. Basically, those companies that are most leveraged to an economy that is healing and coming back online. The areas that would likely most underperform are the “lockdown” stocks.  Unless we see another hard lockdown, we would expect the vaccine news, together with continued vigilance on the part of the general public, to continue to provide hope of a return to normalcy and reopening.


That seems a bit counterintuitive given that many states are curtailing gatherings and leisure activities at the moment given the case surge. I haven’t shown this chart for a while, but I will show the top countries around the world and their statistics. While we do see the new cases spiking for a third time, we aren’t yet seeing the same large spike in deaths (that’s a good thing and hopefully it stays that way). On a side note, researchers in Italy have found that the virus likely started in September of last year (months before the first suspected case), click here if you want to read more.


Finally, as I round out this week’s commentary, it is important to note that our model has shown a big uptick in the favorability of international equities, making one of the biggest point moves since 2009. While it is still in third place right now, it is positioning itself to take over the second-place position currently held by fixed income. We will continue to see how it progresses and continue to act within the constraints of our model and process.

As always, we welcome your comments and questions. In the meantime, we’ll continue to test our assumptions, dig into our research, and lean into our model as we seek to be ever mindful of risk while pursuing long-term returns for your portfolio. Perhaps next week we’ll share some fun Thanksgiving recipes, as it seems more of us may be preparing dinner this year than in the past!